Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia

Anjali S. Advani, MD, Anna Moseley, M.S., Michaela Liedtke, MD, Margaret R O'Donnell, MD, Ibrahim Aldoss, MD, Martha P. Mims, MD PhD, Kristen Marie O'Dwyer, MD, Megan Othus, PhD, Harry P. Erba, MD PhD

Blood (2019) 134 (Supplement_1): 227.

https://doi.org/10.1182/blood-2019-125340

Published: 2019

Journal Articles

Transient Elevations in Markers of Hepatic Function during Pediatric Acute Lymphoblastic Leukemia Treatment Are Common but Do Not Influence Outcomes: A Study of 805 Patients from the Learn Consortium

Joanna S. Yi, MD, Tiffany Chambers, MPH, Kelly D Getz, Tamara P. Miller, MDMSc, Evanette Burrows, MPH, Marla Daves, MD, Philip J. Lupo, PhD MPH, Michael E. Scheurer, PhD MPH, Richard Aplenc, MD PhD, Karen R. Rabin, MD PhD, Maria Monica J. Gramatges, MD PhD

Blood (2019) 134 (Supplement_1): 3814.

https://doi.org/10.1182/blood-2019-123992

Published: 2019

Journal Articles

Comparing the Liver Function of Children with Acute Lymphoblastic Leukemia (ALL) Receiving Standard or High Intensity Treatment during the Interim Maintenance I Phase of Therapy: A Study of 658 Patients

Joanna S. Yi, MD, Tiffany Simone Chambers, BS, Kelly D Getz, PhD, Michael Scheurer, MPH, PhD, Philip J Lupo, PhD, Evanette Burrows, MPH, Marla Daves, MD, Richard Aplenc, MD PhD, Karen R. Rabin, MD PhD, M. Monica Gramatges, MD PhD

Blood (2018) 132 (Supplement 1): 1383.

https://doi.org/10.1182/blood-2018-99-115691

Published: 2018

Journal Articles

A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia (SWOG 1312)

Anjali S. Advani, MD, Anna Moseley, Michaela Liedtke, MD, Margaret O'Donnell, MD, Megan Othus, PhD, Martha P. Mims, MD PhD, Kristen O'Dwyer, MD, Harry P. Erba, MD PhD

Blood (2016) 128 (22): 1634.

https://doi.org/10.1182/blood.V128.22.1634.1634

Published: 2016

Journal Articles

Multiple Myeloma in Patients with HCV-Related Disease:a Case Report

Iolanda D. Vincelli, Patrizia Cufari, Francesco Di Raimondo, MD, Martino Massimo, Massimo Gentile, MD, Fortunato Morabito, Stefania Ciolli, Marco Rossi, MD, Francesca Ronco

Blood (2016) 128 (22): 5700.

https://doi.org/10.1182/blood.V128.22.5700.5700

Published: 2016

Journal Articles

Ruxolitinib As Sparing Agent for Steroid-Dependent Chronic Graft-Versus-Host Disease (cGVHD)

H. Jean Khoury, Vamsi Kota, M.B;B.S, Martha Arellano, MD, Stephanie L Bauer, ANP, Anand P Jillella, MD, Amelia Langston, MD, Zaid Al-Kadhimi, MD, Zachariah DeFilipp, MD, Audrey S Kim, RN, Elliott F. Winton, MD, John F Dipersio, MD PhD

Blood (2015) 126 (23): 1938.

https://doi.org/10.1182/blood.V126.23.1938.1938

Published: 2015

Journal Articles

Lack of Cardiac Iron in SCD Patients Despite Severe Iron Overload

Rasha I Ahmad, MD, Sara Keyrouz, Research coordinator, Mariam Arabi, MD, Fadi Bitar, MD, Wael al Jaroudi, MD, Miguel Abboud, MDHematologist

Blood (2014) 124 (21): 4943.

https://doi.org/10.1182/blood.V124.21.4943.4943

Published: 2014

Journal Articles

Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HCT) In Patients With Relapsed Or Refractory Acute Leukemia

Josefina Serrano, Diana Buenasmañanas, P Herrera, Mari Luz Amigo, Marisa Calabuig, Eusebio Martin, PhD, Maria-Belén Vidriales, Adolfo de la Fuente, M Santero, Silvia Negri, Jose Gonzalez-Campos, Carmen Albo, Sonia Gonzalez, Jose J. Rifon, MD, M Cruz Viguria, V Garcia-Gutierrez, Carmen Martin, Joaquin Sanchez-Garcia

Blood (2013) 122 (21): 3410.

https://doi.org/10.1182/blood.V122.21.3410.3410

Published: 2013

Journal Articles

Longer Follow-Up Of The Combination Of Clofarabine, Idarubicin, and Cytarabine (CIA) As Frontline Therapy For Patients Younger Than 61 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)

Aziz Nazha, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Huang Xuelin, Sangbum Choi, Guillermo Garcia-Manero, MD, Elias Jabbour, MD, Gautam Borthakur, MD, Tapan M. Kadia, MD, Marina Konopleva, MD, PhD, Jorge E. Cortes, MD, Alessandra Ferrajoli, MD, Steven M. Kornblau, MD, Michael Andreeff, MD, PhD, Min Du, Mark Brandt, Stefan H. Faderl, MD

Blood (2013) 122 (21): 1451.

https://doi.org/10.1182/blood.V122.21.1451.1451

Published: 2013

Journal Articles

Pancytopenia a Presentation of disseminated Histoplasmosis

Sakeer Hussain, MD

Blood (2012) 120 (21): 4687.

https://doi.org/10.1182/blood.V120.21.4687.4687

Published: 2012

Journal Articles

Lenalidomide Is Effective Therapy for Relapse After Allogeneic Stem Cell Transplant for Multiple Myeloma.

William I. Bensinger, MD, Damian J. Green, MD, Burwick Nicholas, md, Pamela S Becker, MD, PhD

Blood (2012) 120 (21): 3064.

https://doi.org/10.1182/blood.V120.21.3064.3064

Published: 2012

Journal Articles

The Treatment of ECVP Plus G-Csf on Epstein–Barr Virus-Associated T Lymphoproliferative Disease (EBV+ T-LPD) in Adult

Meihua Qian, Wensong Wang, Manling Wang, Meijuan Wu, Zhongsheng Zhao, Tianxin Yang, Weiqun Jin, Sumei Zhan, Xiaogang Wang, Xing Jin, Ye Peng

Blood (2011) 118 (21): 4384.

https://doi.org/10.1182/blood.V118.21.4384.4384

Published: 2011

Journal Articles

A Phase II Prospective Feasibility Study of Clofarabine Cytoreduction Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Relapsed or Refractory Acute Leukemias and Advanced Myelodysplastic Syndromes

Rajiv Agarwal, BA, Frederick L Locke, MD, Rangesh Kunnavakkam, MS, Koen van Besien, MD, Richard A. Larson, MD, Olatoyosi Odenike, MD, Lucy Godley, MD, PhD, Hongtao Liu, MD, PhD, Michelle M. Le Beau, PhD, Sandeep Gurbuxani, MBBS, PhD, Michael J Thirman, MD, Dorothy A. Sipkins, M.D., Ph.D., Carol White, APN, Andrew Artz, MD, MS, Wendy Stock, MD

Blood (2011) 118 (21): 496.

https://doi.org/10.1182/blood.V118.21.496.496

Published: 2011

Journal Articles

Trough Level of First Dose of Busulfan (Cmin1) Is a Stronger Predictor of Graft Rejection Than Steady State Concentration (Css1) In Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Poonkuzhali Balasubramanian, Ph.D, Salamun Desire, M.Sc, Pranavi Sugumaran, M.Sc, Kavitha ML, M.Sc, Aby Abraham, MD, DM, Auro Viswabandya, MD, DM, Biju George, MD, DM, Vikram Mathews, MD, DM, Mammen Chandy, MD, Rajagopal Krishnamoorthy, D.Sc, Alok Srivastava, MD

Blood (2010) 116 (21): 518.

https://doi.org/10.1182/blood.V116.21.518.518

Published: 2010

Journal Articles

Immune Gene Therapy for Patients with CLL Using Repeat Dose Intranodal Injection of Ad-ISF35, a Replication Incompetent Vector Expressing a Membrane-Stable CD40 Binding Protein.

Januario E Castro, M.D, Johanna Melo-Cardenas, B.Sc, Juan Sebastian Barajas-Gamboa, M.D, Ramin Sean Pakbaz, M.D, Mauricio Urquiza, PhD, Thomas J. Kipps, MD, PhD

Blood (2010) 116 (21): 1476.

https://doi.org/10.1182/blood.V116.21.1476.1476

Published: 2010

Journal Articles

Angiogenic Molecules and Inflammatory Cytokines in Patients with Thalassemia Major and Double Heterozygous HbS/Beta-Thalassemia; the impact of Deferasirox.

Ersi Voskaridou, Dimitrios Christoulas, Athanasios Papatheodorou, Eleni Plata, Charoula Xirakia, Panayiotis Tsaftaridis, Georgios Boutsikas, Evangelos Terpos

Blood (2009) 114 (22): 2018.

https://doi.org/10.1182/blood.V114.22.2018.2018

Published: 2009

Journal Articles

Phase 2 Study of Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome- Outcome in Previously Untreated Patients.

Gautam Borthakur, Guillermo Garcia-Manero, MD, Zeev Estrov, MD, Marina Konopleva, MD, PhD, Jan A. Burger, MD, PhD, Deborah A. Thomas, MD, Tapan Kadia, MD, Betsy Williams, RN, Solly George, Hagop Kantarjian, MD

Blood (2009) 114 (22): 1053.

https://doi.org/10.1182/blood.V114.22.1053.1053

Published: 2009

Journal Articles

Deferasirox Reduces Serum TNF-α but Impairs Renal Function in Patients with Thalassemia Major after 12 Months of Therapy

Ersi Voskaridou, Eleni Plata, Dimitrios Christoulas, Charoula Xirakia, Eleni Stoupa, Konstantinos Varvagiannis, Antonios Bilalis, Athanasios Papatheodorou, Panagiotis Tsaftaridis, Evangelos Terpos

Blood (2008) 112 (11): 3888.

https://doi.org/10.1182/blood.V112.11.3888.3888

Published: 2008

Journal Articles

AHOD0321: A COG Phase 2 Study of Weekly Gemcitabine and Vinorelbine for Children with Recurrent or Refractory Hodgkin Disease.

Peter D. Cole, MD, Tanya M. Trippett, MD, Richard A. Drachtman, MD, Pedro de Alarcon, MD, Lu Chen, Cindy L. Schwartz, MD

Blood (2007) 110 (11): 2318.

https://doi.org/10.1182/blood.V110.11.2318.2318

Published: 2007

Journal Articles

A Phase 1 Trial of Daily Oral Green Tea Extract in Asymptomatic, Rai Stage 0–II Patients with Chronic Lymphocytic Leukemia.

T.D. Shanafelt, MD, S.H. Kaufmann, MD/PhD, T.G. Call, MD, Clive S. Zent, MD, W. Wu, PhD, D.A. Bowen, C. Secreto, A.K. Ghosh, PhD, B. Kabat, C.S. Yang, D.F. Jelinek, PhD, C. Erlichman, MD, Neil E. Kay, MD

Blood (2007) 110 (11): 2047.

https://doi.org/10.1182/blood.V110.11.2047.2047

Published: 2007

NARROW

SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia

Transient Elevations in Markers of Hepatic Function during Pediatric Acute Lymphoblastic Leukemia Treatment Are Common but Do Not Influence Outcomes: A Study of 805 Patients from the Learn Consortium

Comparing the Liver Function of Children with Acute Lymphoblastic Leukemia (ALL) Receiving Standard or High Intensity Treatment during the Interim Maintenance I Phase of Therapy: A Study of 658 Patients

A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia (SWOG 1312)

Multiple Myeloma in Patients with HCV-Related Disease:a Case Report

Ruxolitinib As Sparing Agent for Steroid-Dependent Chronic Graft-Versus-Host Disease (cGVHD)

Lack of Cardiac Iron in SCD Patients Despite Severe Iron Overload

Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HCT) In Patients With Relapsed Or Refractory Acute Leukemia

Longer Follow-Up Of The Combination Of Clofarabine, Idarubicin, and Cytarabine (CIA) As Frontline Therapy For Patients Younger Than 61 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)

Pancytopenia a Presentation of disseminated Histoplasmosis

Lenalidomide Is Effective Therapy for Relapse After Allogeneic Stem Cell Transplant for Multiple Myeloma.

The Treatment of ECVP Plus G-Csf on Epstein–Barr Virus-Associated T Lymphoproliferative Disease (EBV+ T-LPD) in Adult

A Phase II Prospective Feasibility Study of Clofarabine Cytoreduction Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Relapsed or Refractory Acute Leukemias and Advanced Myelodysplastic Syndromes

Trough Level of First Dose of Busulfan (Cmin1) Is a Stronger Predictor of Graft Rejection Than Steady State Concentration (Css1) In Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Immune Gene Therapy for Patients with CLL Using Repeat Dose Intranodal Injection of Ad-ISF35, a Replication Incompetent Vector Expressing a Membrane-Stable CD40 Binding Protein.

Angiogenic Molecules and Inflammatory Cytokines in Patients with Thalassemia Major and Double Heterozygous HbS/Beta-Thalassemia; the impact of Deferasirox.

Phase 2 Study of Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome- Outcome in Previously Untreated Patients.

Deferasirox Reduces Serum TNF-α but Impairs Renal Function in Patients with Thalassemia Major after 12 Months of Therapy

AHOD0321: A COG Phase 2 Study of Weekly Gemcitabine and Vinorelbine for Children with Recurrent or Refractory Hodgkin Disease.

A Phase 1 Trial of Daily Oral Green Tea Extract in Asymptomatic, Rai Stage 0–II Patients with Chronic Lymphocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only